New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- AM Rx today announced the expansion of its online weight-management program, including a dedicated insurance-support pathway for eligible patients who ...

CVS Health said it will restore coverage of Eli Lilly's blockbuster weight loss injection Zepbound and start covering its new obesity pill on its standard drug plans. The move supports Lilly's efforts ...

All major US pharmacy benefit managers now cover Lilly's obesity treatments CVS includes Foundayo as a co-preferred weight-loss drug starting Monday It will restart Zepbound coverage on October 1 Sign ...

CVS Health’s (CVS) pharmacy benefit manager, CVS Caremark, announced on Thursday updates to its most common commercial formularies, including a decision to restore coverage for Eli Lilly’s (LLY) ...

The top pharmacy benefit manager (PBM) in the U.S., CVS Caremark, will restore coverage to obesity products from Eli Lilly, allowing a significant number of patients to gain access to the drugs ...

INDIANAPOLIS, May 28, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an access milestone in obesity care: all three of the nation's largest pharmacy benefit managers (PBMs) ...

Kristi Turner had lost 108 pounds on Zepbound when her insurer cut her off. For 10 months, her prescription was available with a $25 copay through her husband's employer health insurance. The now ...